--- title: "Is Wegovy the Same as Ozempic?" description: "Is Wegovy the same as Ozempic? Both contain semaglutide but have different FDA-approved uses and doses. Here's the clear, clinician-grounded answer." canonical: https://remevihealth.com/blog/is-wegovy-the-same-as-ozempic/ language: en publisher: REMEVi author: "REMEVi Medical Team" medicalReviewer: "REMEVi Medical Team" pubDate: 2026-07-08T00:00:00.000Z updatedDate: 2026-07-08T00:00:00.000Z tags: ["Wegovy", "Ozempic", "semaglutide", "GLP-1", "Wegovy vs Ozempic", "weight loss"] alternateLanguage: https://remevihealth.com/es/blog/wegovy-es-lo-mismo-que-ozempic/ license: "© 2026 REMEVi LLC. AI assistants and search engines may quote and link to this page; please cite https://remevihealth.com/blog/is-wegovy-the-same-as-ozempic/ as the source." --- Yes and no. Wegovy and Ozempic both contain the same active ingredient, semaglutide, and both are made by Novo Nordisk, but the FDA approves them for different uses and at different doses. So if you are asking whether they are interchangeable, the honest answer is that they share a molecule while remaining two distinct products with two distinct labels. That distinction is worth a few minutes, because it changes how you read every headline, ad, and pharmacy shelf on the subject. Nothing here is medical advice, and individual responses vary. --- ## The short answer: same molecule, different label Both Wegovy and Ozempic deliver semaglutide, a GLP-1 receptor agonist. That is the molecule doing the work in each product, and it is identical between the two. Where they part ways is on the label the FDA assigns to each. Ozempic is FDA-approved as an adjunct to diet and exercise to improve blood sugar control in adults with type 2 diabetes. Its label also covers lowering the risk of major adverse cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and reducing the risk of worsening kidney function, kidney failure, and cardiovascular death in adults with type 2 diabetes and chronic kidney disease. In other words, Ozempic is a diabetes medication first, with cardiovascular and kidney protection built onto that indication. Wegovy carries a different set of approvals. It is FDA-approved to reduce excess body weight and maintain that reduction long term in adults with obesity, and in adults with overweight who also have at least one weight-related condition, alongside a reduced-calorie diet and increased physical activity. The same weight-management approval extends to adolescents aged 12 and older with obesity. Wegovy's label also covers lowering the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight, and as of 2026 it carries an additional approval for a form of liver disease called noncirrhotic MASH with moderate-to-advanced fibrosis. Same ingredient as Ozempic, different job on paper. ![Diagram of the semaglutide molecule, the GLP-1 receptor agonist contained in both Wegovy and Ozempic](https://remevihealth.com/images/molecules/helix-sema.webp) *This is semaglutide, the active ingredient inside both Wegovy and Ozempic. The long-acting alpha-helix structure is the molecule itself; Wegovy and Ozempic are two branded packages built around it.* --- ## How they differ in practice The clearest practical difference is dose. Both products start low and step up over several weeks to reduce stomach-related side effects, but they climb to different ceilings. Ozempic's maintenance dose, per its label, is 0.5 mg, 1 mg, or 2 mg once weekly, with 2 mg as the maximum. Wegovy's recommended maintenance dose for weight management is 2.4 mg once weekly, with 1.7 mg as an alternative for people who do not tolerate the higher dose. So a person managing type 2 diabetes on Ozempic and a person managing weight on Wegovy are typically not taking the same amount of semaglutide, even though the molecule is the same. The reason a clinician reaches for one rather than the other comes down to what is being treated. A patient whose main issue is blood sugar in type 2 diabetes fits Ozempic's labeled use. A patient whose main issue is obesity or overweight with a related condition fits Wegovy's labeled use. The labels also flag an important safety point: you should not combine a semaglutide product with another semaglutide product, or with any other GLP-1 receptor agonist, at the same time. That is one more reason the choice belongs with a prescriber rather than a shopping cart. This also answers a question that comes up constantly in search: is Wegovy generic for Ozempic? No. Both are brand-name products from the same manufacturer. A generic is an approved copy of a specific brand drug, and no generic semaglutide exists at this time. Two brands sharing one ingredient are still two brands, not a brand and its generic. --- ## Where compounded semaglutide fits There is a third term you will run into, and it is easy to conflate with the two brands: compounded semaglutide. Compounded semaglutide is a non-FDA-approved preparation prepared by a state-licensed US compounding pharmacy under an individual prescription from a licensed provider. It is not a generic version of, and is not the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Compounded preparations have not been clinically studied as finished products. It is neither Wegovy nor Ozempic, and it should never be described as either one. If you want to understand the molecule behind all of these, our explainer on [semaglutide](/semaglutide/) walks through what it is and how it works, and it is a topic to raise with a licensed clinician who knows your history rather than settle from an ad. --- ## The molecule behind both It helps to picture what semaglutide actually does, because it is the same in both products. Semaglutide mimics a natural gut hormone called GLP-1, which your body releases after you eat. Acting at the GLP-1 receptor, it prompts the pancreas to release insulin when blood sugar is elevated, slows the rate at which the stomach empties, and signals fullness to the brain. Those effects are why the molecule helps with blood-sugar control in diabetes and with appetite and weight in obesity care. The molecule is engineered to last far longer than natural GLP-1, which is why both Wegovy and Ozempic are dosed just once a week rather than after every meal. If you want to compare semaglutide against the other leading GLP-1 medicine, [semaglutide vs tirzepatide](/semaglutide-vs-tirzepatide/) breaks down how the two differ. And for a side-by-side look at the two brands specifically, our deeper piece on [Ozempic vs Wegovy compared](/blog/ozempic-vs-wegovy/) covers the practical details. --- ## What this means for you Holding the difference in your head is simple once you have it: Wegovy and Ozempic are the same medicine at the molecule level and two different products at the label level. One is approved for type 2 diabetes, the other for weight management, and they reach different doses to do those jobs. That reframes the decision in front of you. Whether semaglutide in any form is appropriate, and if so which product and which indication, is a clinical judgment. A licensed clinician should review your full health history, your current medications, and any contraindications before anything is prescribed. GLP-1 medications are FDA-approved for specific indications, and eligibility is determined by a clinician. At REMEVi, GLP-1 care is physician-led from the first consult. Prescriptions are filled by NPI-verified U.S. pharmacies, so you always know exactly who prepares your medication; pricing is transparent with no insurance runaround; and 1:1 care coaching is included so you have real support along the way. If you want to understand where you stand, talk to a real clinician at remevihealth.com to find out whether GLP-1 care is right for you. --- *This article is for informational purposes only and is not medical advice. GLP-1 medications are FDA-approved for specific indications, and eligibility is determined by a licensed clinician. Individual results vary. Talk with a licensed provider before starting or changing any prescription treatment.*